journal article·2022Open access

Materdicine and Medmaterial

Hui HUANG, Yu CHEN

Journal of Inorganic Materials· Volume 37· Issue 11

Abstract

The robust development of clinical medicine and biomaterials boosts diagnostic imaging, effective treatment, and precise theranostics in various diseases. The emerging interdiscipline of materials and medicine, termed as materdicine, aims to surmount the critical obstacles and challenges faced by traditional medicine, such as systemic toxicity, poor bioavailability, inferior site-targeting specificity, and unsatisfing diagnostic/therapeutic efficacy. Herein, the state-of-the-art advances regarding the applications of diverse medmaterials for disease diagnosis, therapy, and theranostics are systematically summarized in this review, especially focusing on the nanoscale medmaterials. We firstly emphasize and discuss biomedical imaging (e.g., optical imaging, magnetic resonance imaging, ultrasound imaging, computed tomography imaging) and therapeutic strategies (e.g., photothermal therapy, dynamic therapy, immunotherapy, synergistic therapy) in the field of cancer treatment. Furthermore, we highlight the important progress of medmaterials in the diagnosis and treatment of other kinds of diseases including orthopedic diseases, respiratory
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Bone Tissue Engineering Materials · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. MALEKJAHANI A, SINDHWANI S, SYED A M, et al. Engineering steps for mobile point-of-care diagnostic devices. Accounts of Chemical Research, 2019, 52(9): 2406-2414.10.1021/acs.accounts.9b00200 ↗
2. HE H, LIU L, MORIN E E, et al. Survey of clinical translation of cancer nanomedicines—lessons learned from successes and failures. Accounts of Chemical Research, 2019, 52(9): 2445-2461.10.1021/acs.accounts.9b00228 ↗
3. HUANG H, FENG W, CHEN Y, et al. Inorganic nanoparticles in clinical trials and translations. Nano Today, 2020, 35: 100972-24.10.1016/j.nantod.2020.100972 ↗
4. HUANG H, FENG W, CHEN Y. Two-dimensional biomaterials: material science, biological effect and biomedical engineering applications. Chemical Society Reviews, 2021, 50(20): 11381-11485.10.1039/D0CS01138J ↗
5. PELAZ B, ALEXIOU C H, ALVAREZ-PUEBLA R A, et al. Diverse applications of nanomedicine. ACS Nano, 2017, 11(3): 2313-2381.10.1021/acsnano.6b06040 ↗
6. BURDA C, CHEN X, NARAYANAN R, et al. Chemistry and properties of nanocrystals of different shapes. Chemical Reviews, 2005, 105(4): 1025-1102.10.1021/cr030063a ↗
7. XIANG H, CHEN Y. Materdicine: interdiscipline of materials and medicine. VIEW, 2020, 1(3): 20200016-29.10.1002/VIW.20200016 ↗
8. SHI J J, KANTOFF P W, WOOSTER R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nature Reviews Cancer, 2017, 17(1): 20-37.10.1038/nrc.2016.108 ↗
9. IRBY D, DU C, LI F. Lipid-drug conjugate for enhancing drug delivery. Molecular Pharmaceutics, 2017, 14(5): 1325-1338.10.1021/acs.molpharmaceut.6b01027 ↗
10. MURA S, NICOLAS J, COUVREUR P. Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 2013, 12(11): 991-1003.10.1038/nmat3776 ↗
11. NICOLAS J, MURA S, BRAMBILLA D, et al. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chemical Society Reviews, 2013, 42(3): 1147-1235.10.1039/C2CS35265F ↗
12. KUNJACHAN S, EHLING J, STORM G, et al. Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects. Chemical Reviews, 2015, 115(19): 10907-10937.10.1021/cr500314d ↗
13. CHEN H M, ZHANG W Z, ZHU G Z, et al. Rethinking cancer nanotheranostics. Nature Reviews Materials, 2017, 2(7): 17024-18.10.1038/natrevmats.2017.24 ↗
14. WANG C, HUANG W, ZHOU Y, et al. 3D printing of bone tissue engineering scaffolds. Bioactive Materials, 2020, 5(1): 82-91.10.1016/j.bioactmat.2020.01.004 ↗
15. KAUR B, KUMAR S, KAUSHIK B K. Recent advancements in optical biosensors for cancer detection. Biosensors and Bioelectronics, 2022, 197: 113805-11.10.1016/j.bios.2021.113805 ↗
16. HUH A J, KWON Y J. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Journal of Controlled Release, 2011, 156(2): 128-145.10.1016/j.jconrel.2011.07.002 ↗
17. DUAN Y, LIU B. Recent advances of optical imaging in the second near-infrared window. Advanced Materials, 2018, 30(47): 1802394-19.10.1002/adma.201802394 ↗
18. HUANG L Y, ZHU S, CUI R, et al. Noninvasive in vivo imaging in the second near-infrared window by inorganic nanoparticle-based fluorescent probes. Analytical Chemistry, 2019, 92(1): 535-542.10.1021/acs.analchem.9b04156 ↗
19. LIN H, GAO S, DAI C, et al. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows. Journal of the American Chemical Society, 2017, 139(45): 16235-16247.10.1021/jacs.7b07818 ↗
20. YANG Q, HU Z, ZHU S, et al. Donor engineering for NIR-II molecular fluorophores with enhanced fluorescent performance. Journal of the American Chemical Society, 2018, 140(5): 1715-1724.10.1021/jacs.7b10334 ↗
21. YANG H C, LI R F, ZHANG Y J, et al. Colloidal alloyed quantum dots with enhanced photoluminescence quantum yield in the NIR-II window. Journal of the American Chemical Society, 2021, 143(6): 2601-2607.10.1021/jacs.0c13071 ↗
22. FAN Y, WANG S, ZHANG F. Optical multiplexed bioassays for improved biomedical diagnostics. Angewandte Chemie International Edition, 2019, 131(38): 13342-13353.10.1002/ange.201901964 ↗
23. WELSHER K, LIU Z, SHERLOCK SP, et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nature Nanotechnology, 2009, 4(11): 773-780.10.1038/nnano.2009.294 ↗
24. CHANG B, LI D, REN Y, et al. A phosphorescent probe for in vivo imaging in the second near-infrared window. Nature Biomedical Engineering, 2022, 6(6): 629-639.10.1038/s41551-021-00773-2 ↗
25. WANG Q, LIANG Z, LI F, et al. Dynamically switchable magnetic resonance imaging contrast agents. Exploration, 2021, 1(2): 20210009-8.10.1002/EXP.20210009 ↗
26. KIM D, KIM J, PARK Y I, et al. Recent development of inorganic nanoparticles for biomedical imaging. ACS Central Science, 2018, 4(3): 324-336.10.1021/acscentsci.7b00574 ↗
27. XU Z, LIU C, ZHAO S, et al. Molecular sensors for NMR-based detection. Chemical Reviews, 2018, 119(1): 195-230.10.1021/acs.chemrev.8b00202 ↗
28. CHO M H, SHIN S H, PARK S H, et al. Targeted, stimuli-responsive, and theranostic 19F magnetic resonance imaging probes. Bioconjugate Chemistry, 2019, 30(10): 2502-2518.10.1021/acs.bioconjchem.9b00582 ↗
29. ZHAO X, DUAN G, WU K, et al. Intelligent metamaterials based on nonlinearity for magnetic resonance imaging. Advanced Materials, 2019, 31(49): 1905461-7.10.1002/adma.201905461 ↗
30. DELCASSIAN D, LUZHANSKY I, SPANOUDAKI V, et al. Magnetic retrieval of encapsulated beta cell transplants from diabetic mice using dual-function MRI visible and retrievable microcapsules. Advanced Materials, 2020, 32(16): 1904502-10.10.1002/adma.201904502 ↗
31. ZHANG J, YUAN Y, GAO M, et al. Carbon dots as a new class of diamagnetic chemical exchange saturation transfer (diacest) MRI contrast agents. Angewandte Chemie International Edition, 2019, 58(29): 9871-9875.10.1002/anie.201904722 ↗
32. ZHANG P, HOU Y, ZENG J, et al. Coordinatively unsaturated Fe3+ based activatable probes for enhanced MRI and therapy of tumors. Angewandte Chemie International Edition, 2019, 58(32): 11088- 11096.10.1002/anie.201904880 ↗
33. DAI C, CHEN Y, JING X X, et al. Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging- guided photothermal tumor ablation. ACS Nano, 2017, 11(12): 12696-12712.10.1021/acsnano.7b07241 ↗
34. DAI C, LIN H, XU G, et al. Biocompatible 2D titanium carbide (MXenes) composite nanosheets for pH-responsive MRI-guided tumor hyperthermia. Chemistry of Materials, 2017, 29(20): 8637-8652.10.1021/acs.chemmater.7b02441 ↗
35. LIU Z, LIN H, ZHAO M L, et al. 2D superparamagnetic tantalum carbide composite MXenes for efficient breast-cancer theranostics. Theranostics, 2018, 8(6): 1648-1664.10.7150/thno.23369 ↗
36. LIU Z, ZHAO M L, LIN H, et al. 2D magnetic titanium carbide MXene for cancer theranostics. Journal of Materials Chemistry B, 2018, 6(21): 3541-3548.10.1039/C8TB00754C ↗
37. CAO Y, WU T, ZHANG K, et al. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano, 2019, 13(2): 1499-1510.10.1021/acsnano.8b07224 ↗
38. BAR-ZION A, NOURMAHNAD A, MITTELSTEIN D R, et al. Acoustically triggered mechanotherapy using genetically encoded gas vesicles. Nature Nanotechnology, 2021, 16(12): 1403-1412.10.1038/s41565-021-00971-8 ↗
39. LIU Y, BHATTARAI P, DAI Z, et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chemical Society Reviews, 2019, 48(7): 2053-2108.10.1039/C8CS00618K ↗
40. LI X, CAI Z, JIANG L P, et al. Metal-ligand coordination nanomaterials for biomedical imaging. Bioconjugate Chemistry, 2019, 31(2): 332-339.10.1021/acs.bioconjchem.9b00642 ↗
41. MENG Z, ZHOU X, SHE J, et al. Ultrasound-responsive conversion of microbubbles to nanoparticles to enable background-free in vivo photoacoustic imaging. Nano Letters, 2019, 19(11): 8109-8117.10.1021/acs.nanolett.9b03331 ↗
42. CHEN Y S, ZHAO Y, YOON S J, et al. Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window. Nature Nanotechnology, 2019, 14(5): 465-472.10.1038/s41565-019-0392-3 ↗
43. KIM J, CHHOUR P, HSU J, et al. Use of nanoparticle contrast agents for cell tracking with computed tomography. Bioconjugate Chemistry, 2017, 28(6): 1581-1597.10.1021/acs.bioconjchem.7b00194 ↗
44. ZHOU B G, YIN H H, DONG C H, et al. Biodegradable and excretable 2D W1.33C i-MXene with vacancy ordering for theory- oriented cancer nanotheranostics in near-infrared biowindow. Advanced Science, 2021, 8(24): 2101043-13.10.1002/advs.202101043 ↗
45. XU J, SHI R, CHEN G, et al. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor- modulated bioimaging and chemodynamic/photodynamic therapy. ACS Nano, 2020, 14(8): 9613-9625.10.1021/acsnano.0c00082 ↗
46. JUNG H S, VERWILST P, SHARMA A, et al. Organic molecule- based photothermal agents: an expanding photothermal therapy universe. Chemical Society Reviews, 2018, 47(7): 2280-2297.10.1039/C7CS00522A ↗
47. WANG H, CHANG J, SHI M, et al. A dual-targeted organic photothermal agent for enhanced photothermal therapy. Angewandte Chemie International Edition, 2019, 131(4): 1069-1073.10.1002/ange.201811273 ↗
48. YU Z, HU W, ZHAO H, et al. Generating new cross-relaxation pathways by coating prussian blue on NaNdF4 to fabricate enhanced photothermal agents. Angewandte Chemie International Edition, 2019, 58(25): 8536-8540.10.1002/anie.201904534 ↗
49. JIANG Y, LI J, ZHEN X, et al. Dual-peak absorbing semiconducting copolymer nanoparticles for first and second near-infrared window photothermal therapy: a comparative study. Advanced Materials, 2018, 30(14): 1705980-7.10.1002/adma.201705980 ↗
50. ZHEN X, XIE C, PU K. Temperature-correlated afterglow of a semiconducting polymer nanococktail for imaging-guided photothermal therapy. Angewandte Chemie International Edition, 2018, 130(15): 4002-4006.10.1002/ange.201712550 ↗
51. SMITH A M, MANCINI M C, NIE S. Second window for in vivo imaging. Nature Nanotechnology, 2009, 4(11): 710-711.10.1038/nnano.2009.326 ↗
52. ZHOU J, JIANG Y, HOU S, et al. Compact plasmonic blackbody for cancer theranosis in the near-infrared II window. ACS Nano, 2018, 12(3): 2643-2651.10.1021/acsnano.7b08725 ↗
53. CHENG Y, YANG F, XIANG G, et al. Ultrathin tellurium oxide/ ammonium tungsten bronze nanoribbon for multimodality imaging and second near-infrared region photothermal therapy. Nano Letters, 2019, 19(2): 1179-1189.10.1021/acs.nanolett.8b04618 ↗
54. CUI J, JIANG R, GUO C, et al. Fluorine grafted Cu7S4-Au heterodimers for multimodal imaging guided photothermal therapy with high penetration depth. Journal of the American Chemical Society, 2018, 140(18): 5890-5894.10.1021/jacs.8b00368 ↗
55. SUN S, SONG Y, CHEN J, et al. NIR-I and NIR-II irradiation tumor ablation using NbS2 nanosheets as the photothermal agent. Nanoscale, 2021, 13(43): 18300-18310.10.1039/D1NR05449J ↗
56. XIANG H J, CHEN Y. Energy-converting nanomedicine. Small, 2019, 15(13): 1805339-31.10.1002/smll.201805339 ↗
57. HU H, QIAN X Q, CHEN Y. Microalgae-enabled photosynthetic alleviation of tumor hypoxia for enhanced nanotherapies. Science Bulletin, 2020, 65(22): 1869-1871.10.1016/j.scib.2020.07.019 ↗
58. CHEN B D, XIANG H J, PAN S S, et al. Advanced theragenerative biomaterials with therapeutic and regeneration multifunctionality. Advanced Functional Materials, 2020, 30(34): 2002621-27.10.1002/adfm.202002621 ↗
59. FENG W, CHEN Y. Chemoreactive nanomedicine. Journal of Materials Chemistry B, 2020, 8(31): 6753-6764.10.1039/D0TB00436G ↗
60. LUCKY S S, SOO K C, ZHANG Y. Nanoparticles in photodynamic therapy. Chemical Reviews, 2015, 115(4): 1990-2042.10.1021/cr5004198 ↗
61. CHANG M, FENG W, DING L, et al. Persistent luminescence phosphor as in-vivo light source for tumoral cyanobacterial photosynthetic oxygenation and photodynamic therapy. Bioactive Materials, 2022, 10: 131-144.10.1016/j.bioactmat.2021.08.030 ↗
62. ZHOU L, DONG C, DING L, et al. Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy. Nano Today, 2021, 39: 101212-12.10.1016/j.nantod.2021.101212 ↗
63. SHEN Y, CHEN L, GUAN X, et al. Tailoring chemoimmunostimulant bioscaffolds for inhibiting tumor growth and metastasis after incomplete microwave ablation. ACS Nano, 2021, 15(12): 20414-20429.10.1021/acsnano.1c08826 ↗
64. MELLMAN I, COUKOS G, DRANOFF G. Cancer immunotherapy comes of age. Nature, 2011, 480(7378): 480-489.10.1038/nature10673 ↗
65. RIBAS A, WOLCHOK J D. Cancer immunotherapy using checkpoint blockade. Science, 2018, 359(6382): 1350-1355.10.1126/science.aar4060 ↗
66. MAHONEY K M, RENNERT P D, FREEMAN G J. Combination cancer immunotherapy and new immunomodulatory targets. Nature Reviews Drug Discovery, 2015, 14(8): 561-584.10.1038/nrd4591 ↗
67. VANNEMAN M, DRANOFF G. Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer, 2012, 12(4): 237-251.10.1038/nrc3237 ↗
68. SANG W, ZHANG Z, DAI Y, et al. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. Chemical Society Reviews, 2019, 48(14): 3771-3810.10.1039/C8CS00896E ↗
69. SHIELDS IV CW, WANG L W, EVANS M A, et al. Materials for immunotherapy. Advanced Materials, 2020, 32(13): 1901633-56.10.1002/adma.201901633 ↗
70. NAM J, SON S, PARK K S, et al. Cancer nanomedicine for combination cancer immunotherapy. Nature Reviews Materials, 2019, 4(6): 398-414.10.1038/s41578-019-0108-1 ↗
71. SONG W, MUSETTI S N, HUANG L. Nanomaterials for cancer immunotherapy. Biomaterials, 2017, 148: 16-30.10.1016/j.biomaterials.2017.09.017 ↗
72. CHEUNG A S, MOONEY D J. Engineered materials for cancer immunotherapy. Nano Today, 2015, 10(4): 511-531.10.1016/j.nantod.2015.06.007 ↗
73. LIU Y, WANG L, SONG Q, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti- PD-L1 therapy for malignant pleural effusion. Nature Nanotechnology, 2022, 17(2): 206-216.10.1038/s41565-021-01032-w ↗
74. ZHENG Y, LI X, DONG C, et al. Ultrasound-augmented nanocatalytic ferroptosis reverses chemotherapeutic resistance and induces synergistic tumor nanotherapy. Advanced Functional Materials, 2022, 32(4): 2107529-17.10.1002/adfm.202107529 ↗
75. XU W, DONG C, HU H, et al. Engineering Janus chemoreactive nanosonosensitizers for bilaterally augmented sonodynamic and chemodynamic cancer nanotherapy. Advanced Functional Materials, 2021, 31(37): 2103134-13.10.1002/adfm.202103134 ↗
76. XIANG H, YOU C, LIU W, et al. Chemotherapy-enabled /augmented cascade catalytic tumor-oxidative nanotherapy. Biomaterials, 2021, 277: 121071-12.10.1016/j.biomaterials.2021.121071 ↗
77. WANG H X, LI M, LEE C M, et al. CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery. Chemical Reviews, 2017, 117(15): 9874-9906.10.1021/acs.chemrev.6b00799 ↗
78. LYU Y, HE S S, LI J C, et al. A photolabile semiconducting polymer nanotransducer for near-infrared regulation of CRISPR/ Cas9 gene editing. Angewandte Chemie International Edition, 2019, 58(50): 18197-18201.10.1002/anie.201909264 ↗
79. CHENG Q, WEI T, FARBIAK L, et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nature Nanotechnology, 2020, 15(4): 313-320.10.1038/s41565-020-0669-6 ↗
80. YIN H, ZHOU B, DONG C, et al. CRISPR/Cas9-2D silicene gene-editing nanosystem for remote NIR-II-induced tumor microenvironment reprogramming and augmented photonic tumor ablation. Advanced Functional Materials, 2021, 31(50): 2107093-12.10.1002/adfm.202107093 ↗
81. YIN H, SUN L, PU Y, et al. Ultrasound-controlled CRISPR/Cas9 system augments sonodynamic therapy of hepatocellular carcinoma. ACS Central Science, 2021, 7(12): 2049-2062.10.1021/acscentsci.1c01143 ↗
82. LI M, MA H, HAN F, et al. Microbially catalyzed biomaterials for bone regeneration. Advanced Materials, 2021, 33(49): 2104829-13.10.1002/adma.202104829 ↗
83. ZHOU Y, WU C, CHANG J. Bioceramics to regulate stem cells and their microenvironment for tissue regeneration. Materials Today, 2019, 24: 41-56.10.1016/j.mattod.2018.07.016 ↗
84. LI T, CHANG J, ZHU Y, et al. 3D printing of bioinspired biomaterials for tissue regeneration. Advanced Healthcare Materials, 2020, 9(23): 2000208-17.10.1002/adhm.202000208 ↗
85. STEVENS M M. Biomaterials for bone tissue engineering. Materials Today, 2008, 11(5): 18-25.10.1016/S1369-7021(08)70086-5 ↗
86. DISCHER D E, MOONEY D J, ZANDSTRA P W. Growth factors, matrices, and forces combine and control stem cells. Science, 2009, 324(5935): 1673-1677.10.1126/science.1171643 ↗
87. GEIGER B, SPATZ J P, BERSHADSKY A D. Environmental sensing through focal adhesions. Nature Reviews Molecular Cell Biology, 2009, 10(1): 21-33.10.1038/nrm2593 ↗
88. WANG L, YANG Q, HUO M, et al. Engineering single-atomic iron-catalyst-integrated 3D-printed bioscaffolds for osteosarcoma destruction with antibacterial and bone defect regeneration bioactivity. Advanced Materials, 2021, 33(31): 2100150-12.10.1002/adma.202100150 ↗
89. SOMMARIVA M, LE NOCI V, BIANCHI F, et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cellular and Molecular Life Sciences, 2020, 77(14): 2739-2749.10.1007/s00018-020-03452-8 ↗
90. YANG W, PETERS J I, WILLIAMS R O. Inhaled nanoparticles-a current review. International Journal of Pharmaceutics, 2008, 356(1): 239-247.10.1016/j.ijpharm.2008.02.011 ↗
91. MYERSON J W, PATEL P N, RUBEY K M, et al. Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation. Nature Nanotechnology, 2022, 17(1): 86-97.10.1038/s41565-021-00997-y ↗
92. VASARMIDI E, TSITOURA E, SPANDIDOS D A, et al. Pulmonary fibrosis in the aftermath of the COVID-19 era. Experimental and Therapeutic Medicine, 2020, 20(3): 2557-2560.10.3892/etm.2020.8980 ↗
93. CRISAN-DABIJA R, PAVEL C A, POPA I V, et al. “A chain only as strong as its weakest link”: an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19. Journal of Proteome Research, 2020, 19(11): 4327-4338.10.1021/acs.jproteome.0c00387 ↗
94. LEDERER D J, MARTINEZ F J. Idiopathic pulmonary fibrosis. New England Journal of Medicine, 2018, 378(19): 1811-1823.10.1056/NEJMra1705751 ↗
95. RICHELDI L, COLLARD H R, JONES M G. Idiopathic pulmonary fibrosis. Lancet, 2017, 389(10082): 1941-1952.10.1016/S0140-6736(17)30866-8 ↗
96. MERKT W, BUENO M, MORA AL, et al. Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis. Seminars in Cell & Developmental Biology, 2020, 101: 104-110.10.1016/j.semcdb.2019.12.008 ↗
97. MALSIN E S, KAMP D W. The mitochondria in lung fibrosis: Friend or foe? Translational Research, 2018, 202: 1-23.10.1016/j.trsl.2018.05.005 ↗
98. YU G, TZOUVELEKIS A, WANG R, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nature Medicine, 2018, 24(1): 39-49.10.1038/nm.4447 ↗
99. SALEH J, PEYSSONNAUX C, SINGH K K, et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion, 2020, 54: 1-7.10.1016/j.mito.2020.06.008 ↗
100. HUANG T, ZHANG T, JIANG X, et al. Iron oxide nanoparticles augment the intercellular mitochondrial transfer-mediated therapy. Science Advances, 2021, 7(40): eabj0534-15.10.1126/sciadv.abj0534 ↗